Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Ciscom Corp. Strengthens Its Board of Directors with Addition of Two Experienced Industry Leaders (click to learn more) Silver North Options GDR Silver Project, Silvertip-Midway District, Yukon (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Biotechnology
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care... see more

Recent & Breaking News (TSXV:COV)

Covalon’s Award-Winning MediClear PreOp Product Recognized as Innovative Solution to Help Hospitals Reduce Surgical Site Infections

Business Wire April 8, 2019

Mr. Ron Smith Joins Covalon’s Board of Directors and is Appointed Chair of the Audit Committee

Business Wire March 18, 2019

Covalon Announces Voting Results from 2019 Annual and Special Meeting of Shareholders

Business Wire March 8, 2019

Covalon Announces First Quarter Fiscal 2019 Results and Updates Plans for Fiscal 2019

Business Wire February 26, 2019

Covalon Announces Conference Call to Discuss First Quarter Financial Results

Business Wire February 21, 2019

Mr. John Suk Joins Covalon’s Board of Directors

Business Wire January 30, 2019

Dr. Myrna Francis Joins Covalon’s Board of Directors

Business Wire January 28, 2019

Covalon Announces Change of Auditors and Amends and Restates Its Rolling Stock Option Plan

Business Wire January 24, 2019

Covalon Announces Issuance of Stock Options

Business Wire December 27, 2018

Covalon Announces Fiscal 2018 Year-End Results and Plans for Fiscal 2019

Business Wire December 17, 2018

Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results

Business Wire December 17, 2018

Covalon Announces Successful Completion of Operational Integration of AquaGuard Acquisition amid Continued Business Progress

Business Wire October 30, 2018

Covalon to Showcase AquaGuard® and IV Clear™ Products to Over 9,000 Nurses at Prestigious ANCC Magnet Conference

Business Wire October 24, 2018

Covalon Announces Closing of AquaGuard Acquisition Combining Covalon’s Rich Technology Portfolio with AquaGuard’s Excellent Products and Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

Business Wire October 1, 2018

Covalon Announces Issuance of Stock Options

Business Wire September 28, 2018

Covalon to Host Conference Call to Discuss Definitive Agreement to Acquire AquaGuard

Business Wire September 20, 2018

Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States

Business Wire September 20, 2018

Covalon to Showcase IV Clear at AVA Scientific Meeting 2018

Business Wire September 14, 2018

Covalon Announces Another Milestone Quarterly Profit on Excellent Third Quarter Financial Results

Business Wire August 28, 2018

Covalon Announces Receipt of First Payment Under New License Agreement

Business Wire August 20, 2018